Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.

Ito K, Saito S, Yorozu A, Kojima S, Kikuchi T, Higashide S, Aoki M, Koga H, Satoh T, Ohashi T, Nakamura K, Katayama N, Tanaka N, Nakano M, Shigematsu N, Dokiya T, Fukushima M; J-POPS Investigators.

Int J Clin Oncol. 2018 Dec;23(6):1148-1159. doi: 10.1007/s10147-018-1309-0. Epub 2018 Jun 22.

PMID:
29934842
2.

Nationwide, Multicenter, Retrospective Study on High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer.

Yoshioka Y, Kotsuma T, Komiya A, Kariya S, Konishi K, Nonomura N, Ogawa K, Tanaka E, Nishimura K, Fujiuchi Y, Kitamura H, Yamagami T, Yamasaki I, Nishimura K, Teshima T, Nakamura K, Itami J.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):952-961. doi: 10.1016/j.ijrobp.2016.12.013. Epub 2016 Dec 18.

PMID:
28333018
3.

Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.

Ishiyama H, Kamitani N, Kawamura H, Kato S, Aoki M, Kariya S, Matsumura T, Kaidu M, Yoshida K, Hashimoto Y, Noda Y, Lim KHC, Kawase T, Takahashi T, Inaba K, Kumano M, Yoshikawa N, Yoshioka Y, Nakamura K, Hiratsuka J, Itami J, Hayakawa K.

Brachytherapy. 2017 May - Jun;16(3):503-510. doi: 10.1016/j.brachy.2017.01.006. Epub 2017 Feb 17.

PMID:
28222973
4.

Feasibility and early outcome of high-dose-rate Ir-192 brachytherapy as monotherapy in two fractions within 1 day for high-/very high-risk prostate cancer.

Ashida S, Yamasaki I, Tamura K, Shimamoto T, Inoue K, Kariya S, Kobayashi K, Yamagami T, Shuin T.

Mol Clin Oncol. 2016 May;4(5):789-793. Epub 2016 Feb 22.

5.

Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.

Yaogawa S, Ogawa Y, Morita-Tokuhiro S, Tsuzuki A, Akima R, Itoh K, Morio K, Yasunami H, Onogawa M, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2015 Dec 22;8(1). pii: E1. doi: 10.3390/cancers8010001.

6.

Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.

Ogawa Y, Kubota K, Aoyama N, Yamanishi T, Kariya S, Hamada N, Nogami M, Nishioka A, Onogawa M, Miyamura M.

Cancers (Basel). 2015 Nov 17;7(4):2277-89. doi: 10.3390/cancers7040891.

7.

Hippocampal subfield volumes in first episode and chronic schizophrenia.

Kawano M, Sawada K, Shimodera S, Ogawa Y, Kariya S, Lang DJ, Inoue S, Honer WG.

PLoS One. 2015 Feb 6;10(2):e0117785. doi: 10.1371/journal.pone.0117785. eCollection 2015.

8.

Reduction of fibroproliferative changes in irradiated rat lung with soluble transforming growth factor-β receptor.

Nishioka A, Ogawa Y, Kariya S, Hamada N, Nogami M, Inomata T, Ueno H.

Mol Med Rep. 2015 Apr;11(4):2659-63. doi: 10.3892/mmr.2014.3064. Epub 2014 Dec 9.

PMID:
25502978
9.

[The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].

Shimamoto T, Ashida S, Yamasaki I, Kuno T, Fukuhara H, Fukata S, Satake H, Tamura K, Karashima T, Kamata M, Inoue K, Shuin T, Kariya S, Ogawa Y.

Hinyokika Kiyo. 2012 Mar;58(3):143-8. Japanese.

10.

Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.

Ogawa Y, Kubota K, Ue H, Tadokoro M, Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H, Tarutani M, Sano S.

Int J Oncol. 2011 Sep;39(3):553-60. doi: 10.3892/ijo.2011.1069. Epub 2011 Jun 6.

PMID:
21667020
11.

Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.

Tsuzuki A, Ogawa Y, Kubota K, Tokuhiro S, Akima R, Yaogawa S, Itoh K, Yamada Y, Sasaki T, Onogawa M, Yamanishi T, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2011 Sep 9;3(3):3496-505. doi: 10.3390/cancers3033496.

12.
13.

Combination treatment of hydrogen peroxide and X-rays induces apoptosis in human prostate cancer PC-3 cells.

Kariya S, Sawada K, Kobayashi T, Karashima T, Shuin T, Nishioka A, Ogawa Y.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):449-54. doi: 10.1016/j.ijrobp.2009.04.092.

PMID:
19735867
14.

Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II).

Ogawa Y, Kubota K, Ue H, Kataoka Y, Tadokoro M, Miyatake K, Tsuzuki K, Yamanishi T, Itoh S, Hitomi J, Hamada N, Kariya S, Fukumoto M, Nishioka A, Inomata T.

Int J Oncol. 2009 Mar;34(3):609-18.

PMID:
19212665
15.

Choline by magnetic spectroscopy and dynamic contrast enhancement curve by magnetic resonance imaging in neoadjuvant chemotherapy for invasive breast cancer.

Murata Y, Hamada N, Kubota K, Miyatake K, Tadokoro M, Kataoka Y, Ue H, Tsuzuki K, Kariya S, Nishioka A, Ogawa Y.

Mol Med Rep. 2009 Jan-Feb;2(1):39-43. doi: 10.3892/mmr_00000059.

PMID:
21475788
16.

New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.

Ogawa Y, Ue H, Tsuzuki K, Tadokoro M, Miyatake K, Sasaki T, Yokota N, Hamada N, Kariya S, Hitomi J, Nishioka A, Nakajima K, Ikeda M, Sano S, Inomata T.

Oncol Rep. 2008 Jun;19(6):1389-94.

PMID:
18497941
17.

Patients' subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy: comparison with conventional fractionation.

Inomata T, Narabayashi I, Inada Y, Shimbo T, Takahashi M, Tatsumi T, Uesugi Y, Kariya S, Nishioka A, Ogawa Y.

Breast Cancer. 2008;15(1):93-100. doi: 10.1007/s12282-007-0011-2. Epub 2007 Dec 5.

PMID:
18224402
18.

Sentinel lymph node detection using computed tomography lymphography is accurate after neoadjuvant chemotherapy for breast cancer.

Ue H, Ogawa Y, Kariya S, Nakatani K, Tsuzuki K, Miyatake K, Maeda H, Tanaka Y, Sasaguri S.

Oncol Rep. 2007 Jun;17(6):1475-80.

PMID:
17487407
19.

Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy.

Kubota K, Ogawa Y, Nishioka A, Kariya S, Itoh S, Murata Y, Hamada N, Maeda H, Tanaka Y.

Oncol Rep. 2007 Apr;17(4):915-8.

PMID:
17342336
20.

CYP17 polymorphism and tamoxifen-induced hepatic steatosis.

Ohnishi T, Ogawa Y, Saibara T, Nishioka A, Kariya S, Fukumoto M, Onishi S, Yoshida S.

Hepatol Res. 2005 Oct;33(2):178-80.

PMID:
16890174

Supplemental Content

Loading ...
Support Center